Earnings● Neutral

Honeywell beats Q2 estimates, lifts FY26 outlook on 4% organic growth

By AlphaScala Research DeskSource reporting: seekingalpha.comEditorial standards1 views
Honeywell beats Q2 estimates, lifts FY26 outlook on 4% organic growth

Q2 non-GAAP EPS of $4.52 beat by $2.70 as organic sales rose 4%. The company lifted its FY26 adjusted EPS view to $16.90-$17.30 on a $38 billion backlog.

AlphaScala Research Snapshot
Live stock context for companies directly referenced in this story
This panel uses AlphaScala-native stock data — proprietary scoring and live snapshots.

Honeywell International beat second-quarter estimates on both the top and bottom lines, then raised its full-year guidance on the back of a 4% organic sales gain and a record backlog.

Non-GAAP earnings came in at $4.52 a share, well ahead of the $2.70 consensus, the company said in a statement. Revenue rose 4.3% from a year earlier to $9.72 billion, also topping expectations by a wide margin. Organic sales, which strip out currency and M&A effects, were up 4%.

Operating margin came in at 17.9%, while segment margin – a measure the company uses internally – hit 23.1%. Orders rose 4%, pushing the total backlog to roughly $38 billion, a level Honeywell said gives it unusual visibility into the next several quarters.

The company now expects full-year 2026 adjusted earnings of $16.90 to $17.30 a share on revenue of $38.6 billion to $39.0 billion. The prior forecast called for EPS of $16.55 to $17.05 on revenue of $38.3 billion to $38.7 billion.

Honeywell's Alpha Score sits at 41 out of 100, a Mixed reading from the stock market analysis platform. The score reflects the company's steady earnings momentum against the broader Industrials sector.

How this story was producedLast reviewed Jul 23, 2026

Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.

Editorial Policy·Report a correction·Risk Disclaimer